Anticoagulant News and Research

RSS
UNC Hospitals receives NCDR ACTION Registry-GWTG Silver Performance Achievement Award

UNC Hospitals receives NCDR ACTION Registry-GWTG Silver Performance Achievement Award

Preliminary results from Phase 3 AVERROES trial in atrial fibrillation to be presented at cardiology congress 2010

Preliminary results from Phase 3 AVERROES trial in atrial fibrillation to be presented at cardiology congress 2010

CPF urges people to consider clinical trials for pulmonary fibrosis

CPF urges people to consider clinical trials for pulmonary fibrosis

PolyMedix's PMX-60056 Phase 1B/2 dose-ranging clinical study for heparin reversal meets study endpoints

PolyMedix's PMX-60056 Phase 1B/2 dose-ranging clinical study for heparin reversal meets study endpoints

IL releases new HemosIL HIT-Ab(PF4-H) assay

IL releases new HemosIL HIT-Ab(PF4-H) assay

Iverson Genetic Diagnostics receives CMS approval for Warfarin clinical study

Iverson Genetic Diagnostics receives CMS approval for Warfarin clinical study

First generic version of Lovenox receives FDA approval for DVT

First generic version of Lovenox receives FDA approval for DVT

Biomet acquires all assets of Cytosol Laboratories

Biomet acquires all assets of Cytosol Laboratories

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

Phase II trial results of TB-402 presented at International Congress on Thrombosis

Phase II trial results of TB-402 presented at International Congress on Thrombosis

Investigators discover new way to harness thrombin's anti-blood clotting properties

Investigators discover new way to harness thrombin's anti-blood clotting properties

Patients prescribed NSAIDs also receive appropriate measures to prevent UGI problems: Study

Patients prescribed NSAIDs also receive appropriate measures to prevent UGI problems: Study

Alzheimer's disease may damage brain

Alzheimer's disease may damage brain

AGA Medical commences enrollment in AMPLATZER Cardiac Plug clinical trial

AGA Medical commences enrollment in AMPLATZER Cardiac Plug clinical trial

Transcatheter valve-in-valve implantation provides option for high-risk elderly patients

Transcatheter valve-in-valve implantation provides option for high-risk elderly patients

New research evaluating substantial disease burden of PNH presented at European Hematology Association

New research evaluating substantial disease burden of PNH presented at European Hematology Association

Dabigatran Etexilate anticoagulant as effective as Enoxaparin in preventing venous thromboembolism

Dabigatran Etexilate anticoagulant as effective as Enoxaparin in preventing venous thromboembolism

Phase 1B clinical study with PMX-60056 meets safety and efficacy endpoints: PolyMedix

Phase 1B clinical study with PMX-60056 meets safety and efficacy endpoints: PolyMedix

New oral blood-thinning drugs may have dangerous interactions when taken with prescription drugs : Study

New oral blood-thinning drugs may have dangerous interactions when taken with prescription drugs : Study

Aspirin may not be beneficial for young adults with diabetes

Aspirin may not be beneficial for young adults with diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.